The Biobeat Wearable Wristwatch and Patch Receive CE Mark Approval for Non-invasive Cuffless Monitoring of Blood Pressure, as Well as Cardiac Output, Stroke Volume, Pulse and Saturation
Biobeat Widens Lead Over Apple, Fitbit With FDA Nod To Add More Vital Sign Monitoring To Smartwatch – CYBER ERA: Catalyzing the Digital Economy
Biobeat is excited to join forces with Medidata Solutions and be part of the Sensor Cloud Network
BioBeat Chest Patches and COVID-19 - Incarta
Biobeat's devices in a joint clinical study | Biobeat
7 Eye-Catching Wearables at MWC19 | PCMag
Wearables Providing Vital Health Data | Wearable Technologies